NEVANAC TRADE DATA ANALYSIS
Analyze Nevanac export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
NEVANAC – Overview
Eximpedia analyses Nevanac export import records, including data from 44 buyers and 13 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Nevanac Buyers, Suppliers & Shipments
Products Nevanac import markets
Gain insights into Product Nevanac with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049099 | 2.67 | 13 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 1.84 | 18 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30042019 | 1.79 | 8 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049059 | 1.39 | 3 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099000 | 0.94 | 8 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BELGIUM | 5.58 | 66 | 0.00 |
| UNITED STATES | 4.81 | 36 | 0.00 |
| NULL | 0.03 | 1 | 0.00 |
| SWITZERLAND | 0.02 | 1 | 0.00 |
| INDIA | 0.01 | 2 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 4.46 | 20 | 0.00 |
| SANTAMARIA | 0.13 | 19 | 0.00 |
| UA100200 | 1.84 | 18 | 0.00 |
| AEROPUERTO COM. A. MERINO B | 0.19 | 7 | 0.00 |
| NINOY AQUINO INTERNATIONAL AIRPORT | 0.94 | 7 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| NOVARTIS PHARMA PAKISTAN LIMITED | 0.61 | 219 |
| NOVARTIS VIETNAM COMPANY LIMITED | 1.39 | 518 |
| BADM LIMITED LIABILITY COMPANY | 1.40 | 1 |
| NOVARTIS HEALTHCARE PHILS INC | 0.94 | 471 |
| NOVARTIS HEALTHCARE PRIVATE LIMITED | 4.22 | 1401 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Nevanac—access key decision-makers and detailed reports to save time and succeed.
Nevanac Import Market
Explore Product Nevanac with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11R2Y (80124 PCS),11UF1 (11868 PCS) (NEPAFENAC OPHTHALMIC SUSPENSION) (IL/FF-000576 RC/FF |  |
|
UNITED STATES | INDIA | 91992 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11UF1 (NEPAFENAC OPHTHALMIC SUSPENSION) (IL/FF-000576 RC/FF-002191 DATE 12-MAY-2022) | |
|
UNITED STATES | INDIA | 76776 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-12AF3 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) | |
|
UNITED STATES | INDIA | 25116 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11YCN (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 91440 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11YCP (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 91068 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-121EH (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 71832 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-122R4 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 92532 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11VTH (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML(X) IN) (IL/FF-000576 RC/FF-0021 | |
|
UNITED STATES | INDIA | 84672 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-122R5 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML)(IL/FF-000576 RC/FF-002191 DATE | |
|
UNITED STATES | INDIA | 91728 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-1263L (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML)(IL/FF-000576 RC/FF-002191 DATE | |
|
UNITED STATES | INDIA | 91272 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-128JW (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 83688 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-1279W (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 93204 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11XEN (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 91872 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11T5T (IL/FF-000576 RC/FF-002191 VALID DATE 14-SEP-2023) (NEPAFENAC OPHTHALMIC SUSPENSION | |
|
UNITED STATES | INDIA | 90348 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-128JV (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 79908 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11XEM (NEPAFENAC OPHT.) (IL/FF-000576 RC/FF-002191 DATE 14 SEP 2023) | |
|
UNITED STATES | INDIA | 91560 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-12E9R (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) | |
|
UNITED STATES | INDIA | 90900 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-12A8M (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 63588 |
| 30049099 | NEVANAC 5ML - IND 741706 BATCH-11VTJ (NEPAFENAC OPHT.) (IL/FF-000576 RC/FF-002191 DATE 14 SEP 2023) | |
|
UNITED STATES | INDIA | 91296 |
| 30042019 | NEVANAC 5ML - IND 741706 BATCH-11UF0 (NEPAFENAC OPHT. SUS. 0.1% W/V LDMO 1MG/ML LDPE 5ML (X) IN) (IL/FF-000576 RC/FF-002 | |
|
UNITED STATES | INDIA | 92232 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Nevanac export markets
Discover Products Nevanac with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30042019 | 0.03 | 98 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099 | 0.01 | 31 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 0.00 | 7 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049069 | 0.00 | 1 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30042099 | 0.00 | 3 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| ANTIGUA AND BARBUDA | 0.01 | 13 | 0.00 |
| CAYMAN ISLANDS | 0.01 | 36 | 0.00 |
| KENYA | 0.01 | 11 | 0.00 |
| BARBADOS | 0.00 | 5 | 0.00 |
| SEYCHELLES | 0.00 | 9 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 0.04 | 100 | 0.00 |
| DELHI AIR CARGO | 0.00 | 20 | 0.00 |
| KPAE | 0.00 | 16 | 0.00 |
| 0.00 | 5 | 0.00 | |
| AHMEDABAD AIR CARGO | 0.00 | 4 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| SAVA HEALTHCARE LIMITED | 0.00 | 627 |
| VEA IMPEX I PRIVATE LIMITED | 0.02 | 1165 |
| KALINDI OVERSEAS | 0.00 | 234 |
| M T MADON EXPORTS | 0.00 | 211 |
| COSMOS HEALTHCARE | 0.00 | 91 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| RANGECHEM PHARMACEUTICALS LIMITED | 0.00 | 17 |
| REGENCY PHARMA LIMITED | 0.00 | 649 |
| TO THE ORDER OF BUYER | 0.00 | 6229 |
Access the complete database of 44 buyers and 13 suppliers with a one-time subscription plan.
Nevanac Export Market
Analyze HSN Code Nevanac with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | GRENADA | 60 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS:NEVANAC OPTHALMICSUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | CAYMAN ISLANDS | 60 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 10 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 10 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 30 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS:NEVANAC OPTHALMICSUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | CAYMAN ISLANDS | 60 |
| 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - DETAILS AS PER ATTACHED EXPORT ANNEXURE INVOICE NO S/329 NEVANAC OP | |
|
INDIA | CAYMAN ISLANDS | 16 |
| 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - DETAILS AS PER ATTACHED EXPORT ANNEXURE INVOICE NO S/329 NEVANAC OP | |
|
INDIA | CAYMAN ISLANDS | 97 |
| 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - DETAILS AS PER ATTACHED EXPORT ANNEXURE INVOICE NO S/329 NEVANAC OP | |
|
INDIA | CAYMAN ISLANDS | 37 |
| 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - DETAILS AS PER ATTACHED EXPORT ANNEXURE INVOICE NO S/329 NEVANAC OP | |
|
INDIA | CAYMAN ISLANDS | 50 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 29 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 49 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 222 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMIC SUSPENSION(5 ML) NEPAFENAC | |
|
INDIA | GRENADA | 16 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 111 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 69 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - NEVANAC OPTHALMIC SUSPENSION (5 ML) (NEPAFENAC) | |
|
INDIA | ANTIGUA AND BARBUDA | 28 |
| 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-NEVANAC OPTHALMICSUSPENSION (5 ML) NEPAFENAC | |
|
INDIA | CAYMAN ISLANDS | 80 |
| 30049099 | NEVANAC OPHTALMIC SOLUTION 5ML COMPOSITION: EACH 5ML CONTAINS: NEPAFENAC 1MG PRESERVATIVE: BENZALKONIUM CHLORIDE NF 0.00 | |
|
INDIA | SEYCHELLES | 24 |
| 30049099 | NEVANAC OPHTALMIC SOLUTION 5ML (COMPOSITION: EACH ML CONTAINS: NEPAFENAC 1MG PRESERVATIVE: BENZALKONIUM CHLORIDE NF 0.00 | |
|
INDIA | SEYCHELLES | 120 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.